H6H
BMY icon

Hightower 6M Holding’s Bristol-Myers Squibb BMY Stock Holding History

Hightower 6M Holding’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.45M Sell
62,627
-26,131
-29% -$1.9M 0.4% 40
2022
Q2 		$6.83M Sell
88,758
-1,323
-1% -$101K 0.57% 25
2022
Q1 		$6.58M Buy
+90,081
New +$6.05M 0.5% 33

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hightower 6M Holding's BMY Position: Q3 2022 in Review

Hightower 6M Holding reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q3 2022, selling an estimated $1.9M and leaving 62,627 shares worth $4.45M. The position accounts for 0.4% of the portfolio, ranked #40.

Hightower 6M Holding first reported a position in BMY in Q1 2022 and has held it in 3 quarters since. The position peaked at $6.83M in Q2 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Hightower 6M Holding held 62,627 shares of Bristol-Myers Squibb worth $4.45M as of Q3 2022.
  • Hightower 6M Holding sold 26,131 Bristol-Myers Squibb shares in Q3 2022, an estimated $1.9M.
  • Bristol-Myers Squibb made up 0.4% of Hightower 6M Holding's portfolio in Q3 2022, its #40 holding.
  • Hightower 6M Holding first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 3 quarters since.
  • Hightower 6M Holding's Bristol-Myers Squibb position peaked at $6.83M in Q2 2022.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.